UAB "Renalfarma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,921,403 |
| 320,234 |
| 65,006 |
| 56,157 |
| 9,360 |
| 37.36 |
| 2.92 |
| 266,333 |
| 477,046 |
| 135,441 |
| 604,633 |
| 2023 |
|---|
| 2,053,315 |
| 342,219 |
| 154,130 |
| 131,571 |
| 21,929 |
| 37.20 |
| 6.41 |
| 356,905 |
| 275,860 |
| 104,683 |
| 525,517 |
| 2024 |
|---|
| 2,010,833 |
| 389,696 |
| 188,260 |
| 161,594 |
| 31,317 |
| 40.65 |
| 8.04 |
| 398,499 |
| 267,819 |
| 75,338 |
| 588,206 |
Register and
explore Okredo data| 2024 |
|---|
| 2,010,833 |
| 389,696 |
| 188,260 |
| 161,594 |
| 31,317 |
| 40.65 |
| 8.04 |
| 398,499 |
| 267,819 |
| 75,338 |
| 588,206 |
Register and
explore Okredo data2024
Turnover (€)
2,010,833 €
-2 % *
Sales per employee (€)
389,696 €
14 % *
Profit before tax (€)
188,260 €22 % *
Net Profit (€)
161,594 €23 % *
Profit per employee (€)
31,317 €43 % *
Total profitability (%)
40.65 %9.27 % *
Net profitability (%)
8.04 %25.43 % *
Equity (€)
398,499 €12 % *
Amounts Payable And Liabilities (€)
267,819 €
-3 % *
Non-current Assets (€)
75,338 €-28 % *
CurrentAssets (€)
588,206 €
12 % *